Approach to osteoporosis diagnosis and fracture risk management in primary care
Canadian Family Physician · 2026
DOI: 10.46747/cfp.7204239 ↗At a glance
Übersichtsarbeit in Canadian Family Physician, 2026. Written by Divya Garg and 5 co-authors. Institution: Clinical Associate Professor in the Department of Family Medicine in the Cumming School of Medicine at the University of Calgary in Alberta. Major MEDLINE topics: Osteoporosis, Osteoporotic Fractures. Cited 2 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
OBJECTIVE: To outline strategies to reduce osteoporosis-related fracture risk through pharmacologic and nonpharmacologic interventions; to examine the role of the Fracture Risk Assessment Tool (FRAX) and bone mineral density (BMD) testing in fracture risk evaluation and periodic monitoring; and to outline evidence-informed interventions for optimizing nutrition, exercise, and pharmacotherapy. SOURCES OF INFORMATION: Recent Canadian guidelines from Osteoporosis Canada, the Canadian Task Force on Preventive Health Care, and the Society of Obstetricians and Gynaecologists of Canada. MAIN MESSAGE: Both BMD testing and FRAX are endorsed by Canadian guidelines for fracture risk assessment. Guidelines support clinical evaluation of fracture risk, particularly in females 65 years or older, with variations in age- and sex-specific screening recommendations between 50 and 64 years. Effective bone health management integrates pharmacologic and nonpharmacologic strategies to prevent falls and fractures. CONCLUSION: Guidelines recommend prioritizing fracture risk screening in females 65 years or older with risk factor assessment and FRAX application. Evaluation should include assessment of fall risk and signs of undiagnosed vertebral fractures. Risk assessment and shared decision making should guide further evaluation with BMD testing. Osteoporosis Canada suggests targeting screening as per fracture risk in postmenopausal females 65 years or younger and males 50 years or older, noting limited supporting evidence. Adults 50 years or older should engage in balance, functional, and resistance training twice weekly, and follow Health Canada's recommendations for calcium and vitamin D intake, including a vitamin D supplement of 400 IU daily. Pharmacologic therapy is recommended for those with prior hip or vertebral fracture, 2 or more osteoporotic fractures, a 10-year fracture risk 20% or higher, or a T-score -2.5 or less and age 70 years or older, guided by patient values and preference.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Clinical Associate Professor in the Department of Family Medicine in the Cumming School of Medicine at the University of Calgary in Alberta.
- Registered dietitian and Graduate Researcher in the Cumming School of Medicine at the University of Calgary.
- Physiotherapist and Exercise Consultant in the Alberta Healthy Living Program at Primary Care Alberta.
- Clinical Associate Professor in the Department of Family Medicine in the Cumming School of Medicine at the University of Calgary.
- Registered dietitian in the Alberta Healthy Living Program at Primary Care Alberta.
- Clinical Assistant Professor in the Division of Endocrinology and Metabolism in the Cumming School of Medicine at the University of Calgary.
Cite
APA
Garg, D., MacLaren, J., Stapleton, C., Bhella, V., Payne, J., & Billington, E. (2026). Approach to osteoporosis diagnosis and fracture risk management in primary care. Canadian Family Physician. https://doi.org/10.46747/cfp.7204239
Vancouver
Garg D, MacLaren J, Stapleton C, Bhella V, Payne J, Billington E. Approach to osteoporosis diagnosis and fracture risk management in primary care. Canadian Family Physician. 2026. doi:10.46747/cfp.7204239
BibTeX
@article{Garg2026,
author = {Garg, Divya and MacLaren, Julia and Stapleton, Candice and Bhella, Vishal and Payne, Janine and Billington, Emma},
title = {Approach to osteoporosis diagnosis and fracture risk management in primary care},
journal = {Canadian Family Physician},
year = {2026},
doi = {10.46747/cfp.7204239}
}
EUVIMED